Management and outcomes of histoplasmosis in youth with inflammatory bowel disease in an endemic area
Objective Patients with inflammatory bowel disease (IBD) prescribed immunosuppressive therapies including antitumor necrosis factor (aTNF) therapies are at increased risk of histoplasmosis. We aim t…